These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20984560)

  • 1. The existence of variations in the ease with which thrombin preparations may be inactivated by antithrombin.
    CARTER JR; SMITH HP
    Fed Proc; 1946; 5(1 Pt 2):219. PubMed ID: 20984560
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on an antithrombin. III. A plasma antithrombin test for the prediction of intravascular clotting.
    KAY JH; HUTTON SB; WEISS GN; OCHSNER A
    Surgery; 1950 Jul; 28(1):24-8. PubMed ID: 15442785
    [No Abstract]   [Full Text] [Related]  

  • 3. Quantitative aspects of antithrombin and heparin in plasma.
    WAUGH DF; FITZGERALD MA
    Am J Physiol; 1956 Mar; 184(3):627-39. PubMed ID: 13302473
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasma content of accelerator and antithrombin active substance in dicumarol induced prothrombinemia].
    HOENE R; MULLER M; SCHULZ W
    Hoppe Seylers Z Physiol Chem; 1953 Jan; 291(5-6):199-212. PubMed ID: 13060907
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in plasma prothrombin, Ac-globulin, and antithrombin concentration following intravenous administration of estrogens.
    JOHNSON JF
    Proc Soc Exp Biol Med; 1957 Jan; 94(1):92-4. PubMed ID: 13400879
    [No Abstract]   [Full Text] [Related]  

  • 6. INTRAVASCULAR COAGULATION AND FIBRINOLYSIS BY STAPHYLOCOAGULASE. COMPARISON WITH THROMBIN.
    JELJASZEWICZ J; NIEWIAROWSKI S; POPLAWSKI A; PROKOPOWICZ J; WOROWSKI K
    Thromb Diath Haemorrh; 1965 Jun; 13():457-69. PubMed ID: 14347867
    [No Abstract]   [Full Text] [Related]  

  • 7. INACTIVATION OF PURIFIED AUTOPROTHROMBIN I WITH ANTITHROMBIN.
    SEEGERS WH; SCHROEER H; KAGAMI M
    Can J Biochem; 1964 Oct; 42():1425-35. PubMed ID: 14240727
    [No Abstract]   [Full Text] [Related]  

  • 8. [Plasma antithrombin and thrombin inhibitor in liver parenchymal and bile duct disease].
    WITTE S; DIRNBERGER P
    Klin Wochenschr; 1955 Aug; 33(29-30):705-9. PubMed ID: 13264505
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombin III: a backward glance o'er travel'd roads.
    Seegers WH
    Adv Exp Med Biol; 1975; 52():195-215. PubMed ID: 47704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombin time and antithrombin power of human plasma in the presence of heparin and some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    J Physiol (Paris); 1955; 47(1):115-7. PubMed ID: 13243272
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombin III. Theory and clinical applications. H. P. Smith Memorial Lecture.
    Seegers WH
    Am J Clin Pathol; 1978 Apr; 69(4):299-359. PubMed ID: 347919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [THE PHYSIOLOGIC INHIBITORS OF BLOOD COAGULATION IN PATHOLOGICALLY INCREASED COAGULABILITY IN VIVO. II. SERUM INFUSION INTO THE BLOOD STREAM].
    SCHIMPF K; CIBELIUS A; MARDINI R
    Klin Wochenschr; 1964 Jul; 42():637-40. PubMed ID: 14248608
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].
    Sakata T
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():626-8. PubMed ID: 15658407
    [No Abstract]   [Full Text] [Related]  

  • 14. INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.
    EGEBERG O
    Thromb Diath Haemorrh; 1965 Jun; 13():516-30. PubMed ID: 14347873
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombin generation and formation of thrombin-antithrombin III complexes in congenital antithrombin III deficiency.
    Boyer C; Wolf M; Lavergne JM; Larrieu MJ
    Thromb Res; 1980 Oct; 20(2):207-18. PubMed ID: 7209877
    [No Abstract]   [Full Text] [Related]  

  • 16. [EVALUATION OF THE ANTITHROMBIN TEST AND THE STARCH TOLERANCE TEST IN THE DIAGNOSIS OF PANCREATIC DISEASES].
    KUBICKI S; LATALLO Z; KACNER J; DOROBA K; WASILEWSKA H
    Pol Tyg Lek; 1964 Oct; 19():1593-6. PubMed ID: 14328847
    [No Abstract]   [Full Text] [Related]  

  • 17. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Antithrombin on the Regimes of Blood Coagulation: Insights from the Mathematical Model.
    Bouchnita A; Galochkina T; Volpert V
    Acta Biotheor; 2016 Dec; 64(4):327-342. PubMed ID: 27718031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANTITHROMBIN ACTIVITY (HEPARIN CO-FACTOR) IN PLASMA AFTER MAJOR SURGERY IN HEPARINIZED PATIENTS.
    OLSSON P; VON FRANCKEN ; NORDSTROEM S
    Acta Chir Scand; 1964 Jun; 127():578-83. PubMed ID: 14175132
    [No Abstract]   [Full Text] [Related]  

  • 20. THE INFLUENCE OF INORGANIC SALTS ON PLASMA ANTITHROMBIN ACTIVITY.
    MONKHOUSE FC
    Thromb Diath Haemorrh; 1963 Jul; 143():387-94. PubMed ID: 14081261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.